AUPH Insider Transactions — Page 2
130 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 101–130; provenance stays internal.
| Insider profile | Role | Date | Transaction | Shares | Price |
|---|---|---|---|---|---|
| Martin Michael Robert | Chief Business Officer | 2021-09-14 | Sale | 30,000.0 | $21.8 |
| Martin Michael Robert | Chief Business Officer | 2021-09-14 | Sale | 14,000.0 | $21.73 |
| Martin Michael Robert | Chief Business Officer | 2021-09-14 | Sale | 90,000.0 | $21.19 |
| Huizinga Robert Bindert | EVP of Research | 2021-09-14 | Sale | 22,500.0 | $21.75 |
| Martin Michael Robert | Chief Business Officer | 2021-09-10 | Sale | 25,000.0 | $19.8 |
| Huizinga Robert Bindert | EVP of Research | 2021-09-10 | Sale | 5,000.0 | $19.76 |
| Huizinga Robert Bindert | EVP of Research | 2021-09-10 | Sale | 5,000.0 | $19.83 |
| Solomons Neil | Chief Medical Officer | 2021-09-10 | Sale | 150,000.0 | $19.84 |
| Martin Michael Robert | Chief Business Officer | 2021-09-07 | Sale | 7,500.0 | $18.1 |
| Huizinga Robert Bindert | EVP of Research | 2021-09-07 | Sale | 5,000.0 | $18.3 |
| Martin Michael Robert | Chief Business Officer | 2021-08-26 | Sale | 22,500.0 | $17.81 |
| Solomons Neil | Chief Medical Officer | 2021-08-25 | Sale | 5,000.0 | $15.85 |
| Solomons Neil | Chief Medical Officer | 2021-08-09 | Sale | 45,000.0 | $16.03 |
| Martin Michael Robert | Chief Business Officer | 2021-08-09 | Sale | 5,000.0 | $16.01 |
| Martin Michael Robert | Chief Business Officer | 2021-07-28 | Sale | 5,000.0 | $13.86 |
| Martin Michael Robert | Chief Business Officer | 2021-06-22 | Sale | 5,000.0 | $13.76 |
| MacKay-Dunn R. Hector | Director | 2021-05-12 | Purchase | 1,600.0 | $11.28 |
| MacKay-Dunn R. Hector | Director | 2021-05-12 | Purchase | 1,400.0 | $11.26 |
| MacKay-Dunn R. Hector | Director | 2021-05-11 | Purchase | 1,000.0 | $11.14 |
| MacKay-Dunn R. Hector | Director | 2021-05-11 | Purchase | 500.0 | $11.17 |
| Donley Matthew Maxwell | Ex VP, Intern'l Operations | 2021-05-11 | Purchase | 9,900.0 | $10.07 |
| Greenleaf Peter | Chief Executive Officer | 2021-05-11 | Purchase | 2,992.0 | $11.11 |
| Greenleaf Peter | Chief Executive Officer | 2021-05-11 | Purchase | 2,133.0 | $10.15 |
| Leversage Jill | Director | 2021-05-11 | Purchase | 2,500.0 | $10.96 |
| Miller Joseph M | Chief Financial Officer | 2021-05-11 | Purchase | 1,000.0 | $9.74 |
| Solomons Neil | Chief Medical Officer | 2021-03-12 | Sale | 40,000.0 | $13.49 |
| MILNE GEORGE M JR | Director | 2021-03-05 | Purchase | 5,000.0 | $13.0 |
| Leversage Jill | Director | 2021-01-29 | Purchase | 1,200.0 | $16.03 |
| Leversage Jill | Director | 2021-01-29 | Purchase | 400.0 | $16.03 |
| Robertson Stephen P. | EVP, General Counsel | 2021-01-28 | Purchase | 900.0 | $16.14 |